Specific inhibitors of 11beta-HSD1
The crucial point in glucocorticoid related diseases, including type 2 diabetes, metabolic syndrome, obesity, hyperglycaemia, arteriosclerosis, dementia, depression and osteoporosis is the ratio of cortisone/cortisol, too much cortisol results in described diseases.
11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) plays an important role in converting cortisone to cortisol, while 11beta-hydroxysteroid dehydrogenase type 2 (11b-HSD2) only acts as a deydrogenase by inactivating cortisol to cortisone. Due to their non-specificity compounds like 18beta-Glycyrrhetinic acid cause adverse effects, among other things hypertension. Therefore, a selective inhibitor of 11b-HSD1 has considerable potential as a drug directed against glucocorticoid related metabolic disorders. The invention results in new compounds with an oleanan or ursan scaffold which specific inhibit 11b-HSD1 and not 11b-HSD2. The structural determinants for specific inhibition are figured out and new approaches to synthesize specific 11b-HSD1 inhibitors with oleanan or ursan scaffold are shown. Selective 11b-HSD1 inhibitors with an oleanan or ursan scaffold should have the advantage of low toxicity, the possibility of modification of the scaffold to influence pharmacokinetic and –dynamic properties, as well as sufficient sources in nature.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Making diamonds at ambient pressure
Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…
Eruption of mega-magnetic star lights up nearby galaxy
Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…
Solving the riddle of the sphingolipids in coronary artery disease
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…